Primemd Inc.
PRMD · OTC
12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,625 | $14,959 | $7,178 | $804 |
| - Cash | $2,590 | $1,585 | $0 | $2,073 |
| + Debt | $7,134 | $7,365 | $0 | $8,216 |
| Enterprise Value | $9,168 | $20,739 | $7,178 | $6,947 |
| Revenue | $1,643 | $3,480 | $4,624 | $755 |
| % Growth | -52.8% | -24.7% | 512.7% | – |
| Gross Profit | $1,643 | $3,480 | $4,624 | $755 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | $3,403 | -$286 | $227 | $691 |
| % Margin | 207.1% | -8.2% | 4.9% | 91.5% |
| Net Income | $2,628 | -$376 | $220 | $668 |
| % Margin | 159.9% | -10.8% | 4.8% | 88.5% |
| EPS Diluted | 0.14 | -0.02 | 0.012 | 0.036 |
| % Growth | 796.5% | -268.9% | -66.7% | – |
| Operating Cash Flow | $4,580 | -$1,429 | -$543 | $410 |
| Capital Expenditures | -$763 | $0 | $0 | -$10 |
| Free Cash Flow | $3,817 | -$1,429 | -$543 | $400 |